Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 5Phase 1 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Suspended 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Burkitt Lymphoma 1

Interventions

Specimen Handling 45pembrolizumab 40Magnetic Resonance Spectroscopy 32Cyclophosphamide 31Biopsy 31fludarabine 27Cetuximab 19Cisplatin 18Carboplatin 18atezolizumab 15Bevacizumab 15Fluorouracil 14venetoclax 13Radiation 13Leucovorin 13fludarabine phosphate 12Radiotherapy 12Gemcitabine 12Pemetrexed 11Oxaliplatin 11Nivolumab 11Cytarabine 10130-nm albumin-bound paclitaxel 10Prednisone 9Paclitaxel 9Irinotecan 9Fulvestrant 9Radiosurgery 8Platinum 8Immunoglobulin G 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × deltacortene × 30 days × Clear all
NCT07278856 2026-06-05

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

City of Hope Medical Center

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, T-Cell

NCT04850495 2026-06-04

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 1 Suspended
38 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05157971 2026-05-28

Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Active not recruiting
24 enrolled
Lymphoid

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡